0.6025
price down icon4.37%   -0.0275
after-market After Hours: .60 -0.0025 -0.41%
loading

Novabay Pharmaceuticals Inc Stock (NBY) Latest News

pulisher
Mar 18, 2025

NovaBay Pharmaceuticals (NBY) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 18, 2025
pulisher
Mar 18, 2025

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decrease in Short Interest - Defense World

Mar 18, 2025
pulisher
Mar 12, 2025

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Share Price Passes Above 50-Day Moving Average – Time to Sell? - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

NovaBay reaches settlements over disputed warrants By Investing.com - Investing.com Australia

Mar 12, 2025
pulisher
Mar 11, 2025

NovaBay reaches settlements over disputed warrants - Investing.com India

Mar 11, 2025
pulisher
Mar 08, 2025

NovaBay Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 08, 2025
pulisher
Mar 07, 2025

Novabay Pharmaceuticals Engages Financial Advisor Should Stockholders Fail To Approve Dissolution Proposal - Marketscreener.com

Mar 07, 2025
pulisher
Mar 07, 2025

NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders - Business Wire

Mar 07, 2025
pulisher
Mar 07, 2025

Will NovaBay Survive? Crucial Stockholder Vote Could Determine Company's Fate - StockTitan

Mar 07, 2025
pulisher
Mar 06, 2025

NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Short Interest Update - Defense World

Mar 06, 2025
pulisher
Mar 01, 2025

StockNews.com Initiates Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World

Mar 01, 2025
pulisher
Feb 27, 2025

Investor Network: NovaBay Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

NovaBay's Avenova Highlighted in National Dry Eye Awareness Month - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 21, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Earns Hold Rating from Analysts at StockNews.com - Defense World

Feb 21, 2025
pulisher
Feb 17, 2025

NovaBay extends CEO's contract through 2025 - MSN

Feb 17, 2025
pulisher
Feb 13, 2025

StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World

Feb 13, 2025
pulisher
Feb 08, 2025

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Crosses Above Fifty Day Moving Average – Time to Sell? - Armenian Reporter

Feb 08, 2025
pulisher
Feb 06, 2025

NovaBay fails to gain shareholder approval for dissolution - MSN

Feb 06, 2025
pulisher
Feb 05, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by Analysts at StockNews.com - ETF Daily News

Feb 05, 2025
pulisher
Feb 04, 2025

NovaBay fails to gain shareholder approval for dissolution By Investing.com - Investing.com Canada

Feb 04, 2025
pulisher
Jan 28, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated at StockNews.com - Defense World

Jan 28, 2025
pulisher
Jan 25, 2025

**NovaBay Pharmaceuticals Completes Asset Sale Transaction and Plans for Dissolution**** - Defense World

Jan 25, 2025
pulisher
Jan 24, 2025

NovaBay Pharmaceuticals Completes the Sale of its Avenova Eyecare Business to PRN, Seeks Full Company Dissolution - Vision Monday

Jan 24, 2025
pulisher
Jan 23, 2025

NovaBay Pharma’s Strategic Shift and Liquidation Plans - TipRanks

Jan 23, 2025
pulisher
Jan 23, 2025

NovaBay Completes $11.5M Avenova Sale to PRN, Pursues Full Company Dissolution - StockTitan

Jan 23, 2025
pulisher
Jan 23, 2025

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal - Business Wire

Jan 23, 2025
pulisher
Jan 23, 2025

NovaBay Pharmaceuticals Extends CEO’s Employment Agreement Until 2025 - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

NovaBay extends CEO's contract through 2025 By Investing.com - Investing.com South Africa

Jan 22, 2025
pulisher
Jan 20, 2025

NovaBay Pharmaceuticals (NYSE:NBY) Coverage Initiated by Analysts at StockNews.com - Defense World

Jan 20, 2025
pulisher
Jan 12, 2025

NovaBay Pharmaceuticals Completes Sale of Wound Care Product Trademarks and Inventory - Defense World

Jan 12, 2025
pulisher
Dec 30, 2024

Novabay Pharmaceuticals Announces Board Changes - Marketscreener.com

Dec 30, 2024
pulisher
Dec 28, 2024

NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Dec 28, 2024
pulisher
Dec 27, 2024

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Shares Cross Above 50 Day Moving Average – Should You Sell? - Defense World

Dec 27, 2024
pulisher
Dec 27, 2024

NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by StockNews.com - Defense World

Dec 27, 2024
pulisher
Dec 25, 2024

NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why - Yahoo Finance

Dec 25, 2024
pulisher
Dec 21, 2024

NovaBay Pharmaceuticals Adjourns Special Meeting Due to Insufficient Votes - Defense World

Dec 21, 2024
pulisher
Dec 19, 2024

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders - BioSpace

Dec 19, 2024
pulisher
Dec 19, 2024

NovaBay Pharmaceuticals Delays Critical Vote on Avenova Sale and Company Dissolution Amid Vote Shortage - StockTitan

Dec 19, 2024
pulisher
Dec 15, 2024

NovaBay®Pharmaceuticals, Inc. Launches NovaWipes Eyelid Wipes on Amazon.com - Marketscreener.com

Dec 15, 2024
pulisher
Dec 10, 2024

NBYNovaBay Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Dec 10, 2024
pulisher
Dec 09, 2024

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting - BioSpace

Dec 09, 2024
pulisher
Nov 25, 2024

NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024 - BioSpace

Nov 25, 2024
pulisher
Nov 22, 2024

NovaBay Postpones Key Vote on Asset Sale, Liquidation Plans Amid Low Turnout | NBY Stock News - StockTitan

Nov 22, 2024
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$33.41
price up icon 0.00%
$20.11
price up icon 1.41%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):